The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Weill Cornell Medical College - $91,740

Amount
$91,740.00
Date
March 2010

Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.

St. Jude's Children's Research Hospital - $10,000

Amount
$10,000.00
Date
July 2009

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
July 2009

National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $50,000

Amount
$50,000.00
Date
July 2009

Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
September 2008

Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $25,000

Amount
$25,000.00
Date
September 2008

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.